ENXTPA:ABVXBiotechs
ABIVAX (ENXTPA:ABVX) EPS Loss Of €2.10 In Q3 Reinforces Bearish Narratives
ABIVAX Société Anonyme (ENXTPA:ABVX) has reported FY 2025 third quarter revenue of €0.639 million and a basic EPS loss of €2.10, while trailing twelve month figures show revenue of €5.311 million and a basic EPS loss of €4.46. Over recent quarters, revenue has moved from €1.351 million in Q3 2024 to €0.97 million in Q1 2025 and €1.047 million in Q2 2025, with basic EPS losses of €0.87, €0.83 and €0.76 across those same periods, and a trailing net loss of €293.52 million anchoring the story...